Indietro

A Randomized, Double-blind, Phase III Study evaluating the Efficacy and Safety of ABP980

A Randomized, Double-blind, Phase III Study evaluating the Efficacy and Safety of ABP980

A Randomized, Double-blind, Phase III Study evaluating the Efficacy and Safety of ABP980 compared with Trastuzumab in subjects with HER-2 positive early breast cancer

A Randomized, Double-blind, Phase III Study evaluating the Efficacy and Safety of ABP980 compared with Trastuzumab in subjects with HER-2 positive early breast cancer

 

PRINCIPAL INVESTIGATOR: Dott. Vito LORUSSO

 

Data di pubblicazione:

02/10/2014

Ultimo aggiornamento:

14/01/2016